ZIBRY
DEAD

Serial Number

86801581

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 28, 2015

Add to watchlist:

No watchlists yet
View on USPTO

ZIBRY Trademark

Serial Number: 86801581

ZIBRY is a trademark filed by NOVARTIS AG on October 28, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 28, 2015

Registration Date

Not Registered

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; Pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of kidney diseases; Pharmaceutical preparations for the prevention and treatment of diabetes; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; Pharmaceutical products for the prevention and treatment of bone diseases; Pharmaceutical products for the prevention and treatment of respiratory diseases and asthma, all of the foregoing excluding pharmaceutical preparations for the treatment of sleep disorders and neurological disorders

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 13, 2017 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 13, 2017 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2017 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 21, 2017 RCCK
ASSIGNED TO LIE
Feb 21, 2017 ALIE
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 17, 2016 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 16, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 16, 2016 GNSL
SUSPENSION LETTER WRITTEN
Feb 16, 2016 CNSL
ASSIGNED TO EXAMINER
Feb 8, 2016 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Feb 2, 2016 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 2, 2016 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2015 NWOS
NEW APPLICATION ENTERED
Oct 31, 2015 NWAP